These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7526656)

  • 1. Direct effects of second-generation H1-receptor antagonists on the activation of human basophils.
    Ramachers U; Amon U; Wolff HH
    Agents Actions; 1994 Jun; 41 Spec No():C45-6. PubMed ID: 7526656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
    Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
    Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
    Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
    Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils.
    Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
    Int Arch Allergy Immunol; 1994 Sep; 105(1):12-7. PubMed ID: 7522069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
    Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
    J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
    Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
    Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pranlukast on histamine release and leukotriene c4 (ltc4) generation from human peripheral basophils].
    Ito R; Miura K; Odajima Y; Shimamura T
    Arerugi; 2004 Jan; 53(1):19-23. PubMed ID: 14762327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils.
    Nabe M; Agrawal DK; Sarmiento EU; Townley RG
    Clin Exp Allergy; 1989 Sep; 19(5):515-20. PubMed ID: 2477125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
    Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
    Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
    Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
    J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells.
    Igarashi Y; Lundgren JD; Doerfler ME; Shelhamer JH; Kaliner MA; White MV
    J Allergy Clin Immunol; 1992 Jun; 89(6):1085-97. PubMed ID: 1376734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils.
    Amon U; Amon S; Gibbs BF
    Inflamm Res; 2000 Apr; 49 Suppl 1():S13-4. PubMed ID: 10864400
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
    Okayama Y; Benyon RC; Lowman MA; Church MK
    Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
    Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
    Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous initiation of degranulation and inhibition of leukotriene release by soman in human basophils.
    Meier HL; Warner J; MacGlashan DW
    Int J Immunopharmacol; 1995 Apr; 17(4):283-9. PubMed ID: 7545649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic activity of loratadine: inhibition of leukotriene C4 release from human leucocytes.
    Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
    Clin Exp Allergy; 1995 Apr; 25(4):364-70. PubMed ID: 7541309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
    Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.